drug
ceftazidime
Marketedupdated 3mo agoby ACS Dobfar SpA
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 4all catalysts(0)
nothing on the calendar yet
Trials studying ceftazidime
- —A Study to Learn About the Study Medicine - Zavicefta in Patients With Sepsis or Loss of Kidney Function in Japan
- phase2Safety, Pharmacokinetics and Efficacy of BV100 Plus Low Dose Polymyxin B Plus Ceftazidime/Avibactam, or Plus Cefiderocol in Patients With Pulmonary and Extrapulmonary Infections Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex
- phase3A Study to Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABP
- —Real-World Study of Ceftazidime Avibactam in China
- N/ACystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified
- phase4Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adults
- phase3Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in CIAI
- phase4Efficacy and Safety of Ceftazidime-Avibactam (CAZ-AVI) in Chinese Participants With HAP (Including VAP)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 36m ago
Found something off?
comments(0)
5-min edit window · permanent after that